Archive for MHRA Updates
Class 4 Medicines Defect Information: OxyContin 20 mg prolonged release tablets, EL (22)A/27
Source: MHRA/ Gov.uk Napp Pharmaceuticals Limited have identified an error relating to the Braille printed on the cartons. The Braille message on the Oxycontin 20mg prolonged release tablets incorrectly states...
Class 4 Medicines Defect Information: Esomeprazole 40mg Powder for Solution for Injection/Infusion, EL (22)A/26
Source: MHRA / Gov.uk 31.5.22 DEMO SA PHARMACEUTICAL INDUSTRY has informed us that the Product Code/GTIN (PC) number found on the above batch is incorrect. The GTIN number that should...
Class 2 Medicines Recall: Quadrant Pharmaceuticals Ltd, Mefenamic Acid 500mg film coated tablets, EL (22)A/23
Source: MHRA / Gov.uk 17.5.22 Quadrant Pharmaceuticals Ltd are recalling a specific batch of Mefenamic Acid 500mg Film-Coated Tablets as a precautionary measure, due to observations of a defective layer...
Shortage of Estradiol (Sandrena) 1mg gel sachets-Medicines Supply Tool update
Source: SPS.nhs.uk * 16th May 22 Status: Supply returning Impact tier: 1 · Low impact Shortage start: – Anticipated re-supply date: 31 May 2022 BNF chapters: 07 – Obstetrics, Gynae & Urinary...
Class 4 Medicines Defect Information: GlaxoSmithKline UK Ltd, Zovirax I.V. 500 mg, EL (22)A/22
Source: MHRA / Gov.uk 9.5.22 GlaxoSmithKline UK Ltd have informed the MHRA that an incorrect version of the Summary of Product Characteristics section 4.2 and the Patient Information Leaflet is...
Health Secretary meets with HRT suppliers to resolve supply issues
Source: Department of Health and Social Care, Maria Caulfield MP, and The Rt Hon Sajid Javid MPPublished5 May 2022 Urgent action continues to be taken to ensure women across the UK...
Class 2 Medicines Recall: Pfizer Limited, Accupro 5mg, 10mg, 20mg, 40mg film-coated tablets, EL(22)A/21
Source: MHRA 5.5.22 Pfizer Limited are recalling all batches of Accupro 5mg, 10mg, 20mg, 40mg film-coated tablets as a precautionary measure MDR number MDR 009-03/22 Company name Pfizer Limited Product...
April 2022 Final Price Concessions Update
Drug Tariff News – April Part VIIIA reimbursement prices (issued 29 April) The Department of Health and Social Care has agreed the April Drug Tariff Part VIIIA reimbursement prices for...
Class 2 Medicines Recall: Fresenius Kabi Limited, Sodium bicarbonate 1.26% Solution for infusion, EL(22)A/20
Source: MHRA 28.4.22 Fresenius Kabi Limited are recalling a specific batch of product as a precautionary measure due to the identification of particles in the solution for injection, following routine...
SSP019 Oestrogel® Pump-Pack 0.06% gel (PDF:167KB)
SSP019 Source: DHSC / NHSBSA SSP Total quantity supplied under this protocol to be equivalent to three months’ supply of the prescribed medicine. Click here for full details
SSP020 Ovestin® 1mg cream (PDF:166KB)
Source: DHSC / NHSBSA SSP SSP020 Total quantity supplied under this protocol to be equivalent to three months’ supply of the prescribed medicine. Click here for full details
SSP021 Premique® low dose 0.3mg/1.5mg modified-release tablets (PDF:166KB)
Source: DHSC / NHSBSA SSP SSP021 Total quantity supplied under this protocol to be equivalent to three months’ supply of the prescribed medicine. Click here for full details
